Boodhoo Kamini Devi, Liu Sijia, Zuo Xiaoxia
Department of Rheumatology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
Medicine (Baltimore). 2016 Jul;95(29):e4272. doi: 10.1097/MD.0000000000004272.
Systemic lupus erythematosus (SLE) is a chronic autoimmune multiorgan disorder of unknown etiology. It affects both men and women, but with different disease manifestations of differing disease severity and in varying proportion, with a female predominance of approximately 90%. There have been numerous studies addressing this issue, especially its implications in relation to optimal sex-tailored treatment and improvement of survival rate; however, further research is warranted. A meta-analysis of studies was performed to compare the impact of sex on the clinical outcomes of SLE in different populations.
A literature search of the MEDLINE/PubMed and EMBASE databases (until January 2016) was conducted to identify relevant articles. Clinical manifestations reported in these patients were considered as endpoints for this meta-analysis. Two independent reviewers determined eligibility criteria. A fixed-effect model has been used where a small heterogeneity was observed, or else, a random-effect model has been used among the studies. Odd ratio (OR) with 95% confidence interval (CI) was used to express the pooled effect on dichotomous variables, and the pooled analyses were performed with RevMan 5.3.
Sixteen studies consisting of a total of 11,934 SLE patients (10,331 females and 1603 males) have been included in this meta-analysis. The average female-to-male ratio of all the included studies is around 9.3:1. Several statistically significant differences were found: alopecia, photosensitivity, and oral ulcers were significantly higher in female patients (OR 0.36, 95% CI 0.29-0.46, P < 0.00001; OR 0.72, 95% CI 0.63-0.83, P < 0.00001; and OR 0.70, 95% CI 0.60-0.82, P < 0.00001, respectively). Malar rash was significantly higher in female patients (OR 0.68, 95% CI 0.53-0.88, P = 0.003), and arthritis was significantly lower in male patients (OR 0.72, 95% CI 1.25-1.84, P < 0.00001). However, serositis and pleurisies were significantly higher in female patients (OR 1.52, 95% CI 1.25-1.84 P < 0.0001; and OR 1.26, 95% CI 1.07-1.48, P = 0.006, respectively). Renal involvement was higher in male patients (OR 1.51, 95% CI 1.31-1.75, P < 0.00001).
The results of this meta-analysis suggest that alopecia, photosensitivity, oral ulcers, arthritis, malar rash, lupus anticoagulant level, and low level of C3 were significantly higher in female lupus patients, whereas renal involvement, serositis and pleurisies, thrombocytopenia, and anti-double stranded deoxyribonucleic acid level were predominant in male patients.
系统性红斑狼疮(SLE)是一种病因不明的慢性自身免疫性多器官疾病。它可影响男性和女性,但疾病表现、严重程度及比例各不相同,女性患病率约占90%。针对这一问题已有大量研究,尤其是其在优化性别针对性治疗及提高生存率方面的意义;然而,仍需进一步研究。本研究通过对多项研究进行荟萃分析,比较性别对不同人群SLE临床结局的影响。
检索MEDLINE/PubMed和EMBASE数据库(截至2016年1月)以确定相关文章。这些患者报告的临床表现被视为本次荟萃分析的终点。两名独立评审员确定纳入标准。若观察到异质性较小,则使用固定效应模型,否则在各项研究中使用随机效应模型。采用比值比(OR)及95%置信区间(CI)表示二分变量的合并效应,并使用RevMan 5.3进行汇总分析。
本荟萃分析纳入了16项研究,共11934例SLE患者(女性10331例,男性1603例)。所有纳入研究的平均男女比例约为9.3:1。发现了一些具有统计学意义的差异:女性患者的脱发、光敏性和口腔溃疡发生率显著更高(OR分别为0.36,95%CI为0.29 - 0.46,P<0.00001;OR为0.72,95%CI为0.63 - 0.83,P<0.00001;OR为0.70,95%CI为0.60 - 0.82,P<0.00001)。女性患者的蝶形红斑发生率显著更高(OR为0.68,95%CI为0.53 - 0.88,P = 0.003),男性患者的关节炎发生率显著更低(OR为0.72,95%CI为1.25 - 1.84,P<0.00001)。然而,女性患者的浆膜炎和胸膜炎发生率显著更高(OR分别为1.52,95%CI为1.25 - 1.84,P<0.0001;OR为1.26,95%CI为1.07 - 1.48,P = 0.006)。男性患者的肾脏受累情况更常见(OR为1.51,95%CI为1.31 - 1.75,P<0.00001)。
本次荟萃分析结果表明,女性狼疮患者的脱发、光敏性、口腔溃疡、关节炎、蝶形红斑、狼疮抗凝物水平及低C3水平显著更高,而男性患者则以肾脏受累、浆膜炎和胸膜炎、血小板减少症及抗双链脱氧核糖核酸水平更为常见。